Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1384890Generated: November 1, 2026

4-Methylmorpholine → CBz-D-phenylglycine 4-[l-(Boc)piperidin-4-yl]piperidinamide

https://huagongshe.com/reaction/1384890

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-MethylmorpholineHCID 7972—
ReactantIsobutyl chloroformateHCID 62365—
Reactant(R)-(((Phenylmethoxy)carbonyl)amino)phenylacetic acidHCID 87183—
Reactant4,4'-Bipiperidine, 1-boc protectedHCID 11747599—
SolventTetrahydrofuranHCID 8028—
ProductCBz-D-phenylglycine 4-[l-(Boc)piperidin-4-yl]piperidinamideHCID 131722771121.1%

Reaction Steps

To a solution of CBz-D-phenylglycine (877 mg, 3.1 mmol) in anhydrous THF (40 ml) at −25° C. was added N-methylmorpholine (336 μl, 3.1 mmol) and isobutyl chloroformate (419 μl, 3.1 mmol). The resulting suspension was left to stir for 5 min at this temperature and then the t-Butyl 4-(piperidin-4-yl)piperidine-1-carboxylate (825 mg, 3.1 mmol) in anhydrous THF (5 ml) was added in one portion at −25° C. and the reaction mixture allowed to warm to room temperature over 1 hour. The N-methylmorpholine hydrochloride was filtered off and the THF removed under vacuo. The resulting solid was treated with TFA/DCM (20 ml, 1:1) and the reaction mixture left to stir for 2 hours. The organics were removed under vacuo, the residue dissolved in ethyl acetate (100 ml), washed with aq. sodium bicarbonate solution, brine, dried and concentrated to yield the title compound as a clear oil (1.12 g, 84% over two steps).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS06262069B1
Source datasetuspto-grants-2001_07
ORD IDord-94a783770e9a4d6c99761c42e2867727
Source noteuspto-grants-2001_07